Basiliximab (CHI 621) is a chimeric mouse/human IgG1 monoclonal recombinant antibody targeting the interleukin-2 receptor, demonstrating potent immunosuppressive activity for use in kidney transplantation studies.
Purity:
95.30%
CAS Number:
[179045-86-4]
Target:
Interleukin
* VAT and and shipping costs not included. Errors and price changes excepted